Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s

Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine’s performance in a real-world setting.

Read the Original Article>>

Source: Medical Xpress

Send this to a friend